{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:17:02Z","timestamp":1788268622095,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cbi.2024.110865","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T04:16:07Z","timestamp":1704514567000},"page":"110865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Vitamin D inhibits tamoxifen-induced non-alcoholic fatty liver disease through a nonclassical estrogen receptor\/liver X receptor pathway"],"prefix":"10.1016","volume":"389","author":[{"given":"Maoxuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5979-2776","authenticated-orcid":false,"given":"Zhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.110865_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"EmjnrG","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.110865_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2024.110865_bib3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMc1006581","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"363","author":"Violi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2024.110865_bib4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2024.110865_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.110865_bib6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2024.110865_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-012-2055-z","article-title":"Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression","volume":"135","author":"Pang","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cbi.2024.110865_bib8","series-title":"Estrogen Receptor and Breast Cancer","first-page":"339","author":"Sommer","year":"2001"},{"key":"10.1016\/j.cbi.2024.110865_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jfma.2015.05.006","article-title":"Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients","volume":"115","author":"Pan","year":"2016","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.cbi.2024.110865_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.clbc.2016.12.004","article-title":"The relationship between tamoxifen-associated nonalcoholic fatty liver disease and the prognosis of patients with early-stage breast cancer","volume":"17","author":"Yan","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.cbi.2024.110865_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00204-018-2345-2","article-title":"The protective role of liver X receptor (LXR) during fumonisin B1-induced hepatotoxicity","volume":"93","author":"Regnier","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110865_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jnutbio.2016.08.007","article-title":"Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity)","volume":"38","author":"Panneerselvam","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.cbi.2024.110865_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tibs.2004.10.005","article-title":"Enzymes involved in the activation and inactivation of vitamin D","volume":"29","author":"Prosser","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cbi.2024.110865_bib14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.beem.2018.09.014","article-title":"Vitamin D insufficiency: definition, diagnosis and management","volume":"32","author":"Bouillon","year":"2018","journal-title":"Best Pract Res Cl En"},{"key":"10.1016\/j.cbi.2024.110865_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/79.3.362","article-title":"Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis","volume":"79","author":"Holick","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.cbi.2024.110865_bib16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/nu9091015","article-title":"Vitamin D supplementation and non-alcoholic fatty liver disease: present and future","volume":"9","author":"Barchetta","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2024.110865_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/hepr.13485","article-title":"Relationship between serum vitamin D level and sarcopenia in chronic liver disease","volume":"50","author":"Okubo","year":"2020","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cbi.2024.110865_bib18","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cbi.2024.110865_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11670-011-0038-y","article-title":"Current status of diagnosis and treatment of primary breast cancer in beijing","volume":"23","author":"Yuan","year":"2008","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.cbi.2024.110865_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1031","article-title":"Tamoxifen: a most unlikely pioneering medicine","volume":"2","author":"Jordan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2024.110865_bib21","first-page":"126","article-title":"Aromatase research and its clinical significance","volume":"61","author":"Czajka-Oraniec","year":"2010","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.cbi.2024.110865_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pharmthera.2013.05.005","article-title":"Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs","volume":"139","author":"Yang","year":"2013","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.cbi.2024.110865_bib23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/appi.ajp.2008.08040482","article-title":"Drug interactions and pharmacogenomics in the treatment of breast cancer and depression","volume":"165","author":"Henry","year":"2008","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.cbi.2024.110865_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(05)78493-2","article-title":"Tamoxifen-induced fatty liver in patients with breast cancer","volume":"351","author":"Yo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2024.110865_bib25","article-title":"Anordrin eliminates tamoxifen side effects without changing its antitumor activity","volume":"7","author":"Gu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.110865_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1871529X18666180302113713","article-title":"Cholesterol homeostasis and liver X receptor (LXR) in atherosclerosis","volume":"18","author":"Guo","year":"2018","journal-title":"Cardiovasc. Hematol. Disord.: Drug Targets"},{"key":"10.1016\/j.cbi.2024.110865_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108778","article-title":"Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease","volume":"113","author":"Ni","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.110865_bib28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/er.2011-1049","article-title":"Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors","volume":"33","author":"Kang","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2024.110865_bib29","article-title":"Liver x receptors stimulate lipogenesis in bovine mammary epithelial cell culture but do not appear to be involved in diet\u2010induced milk fat depression in cows","volume":"2","author":"Harvatine","year":"2014","journal-title":"Phys. Rep."},{"key":"10.1016\/j.cbi.2024.110865_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10911-007-9061-5","article-title":"Lipid synthesis in lactation: diet and the fatty acid switch","volume":"12","author":"Rudolph","year":"2007","journal-title":"J Mammary Gland Biol"},{"key":"10.1016\/j.cbi.2024.110865_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI27883","article-title":"Liver X receptors as integrators of metabolic and inflammatory signaling","volume":"116","author":"Zelcer","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2024.110865_bib32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/228764a0","article-title":"Unique biosynthesis by kidney of a biologically active vitamin D metabolite","volume":"228","author":"Fraser","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2024.110865_bib33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2016.05.031","article-title":"Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis","volume":"65","author":"Bozic","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.110865_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.numecd.2015.02.011","article-title":"A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet","volume":"25","author":"Han","year":"2015","journal-title":"J Nutrition Metabolism & Cardiovascular Diseases Nmcd"},{"key":"10.1016\/j.cbi.2024.110865_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/oby.21757","article-title":"1,25(OH)2D3 attenuates hepatic steatosis by inducing autophagy in mice","volume":"25","author":"Li","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.cbi.2024.110865_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121794","article-title":"Metabolic outcomes and changes in innate immunity induced by diesel exhaust particles airway exposure and high-fat high-sucrose diet","volume":"326","author":"Hasegawa","year":"2023","journal-title":"Life Sci."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:14:28Z","timestamp":1757859268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":36,"alternative-id":["S0009279724000115"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110865","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D inhibits tamoxifen-induced non-alcoholic fatty liver disease through a nonclassical estrogen receptor\/liver X receptor pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110865"}}